浙江大学创立于1897年,坐落于中国历史文化名城、风景旅游胜地杭州。经过126年的建设与发展,学校已成为一所基础坚实、实力雄厚、特色鲜明、在海内外有较大影响的研究型、综合型、创新型大学,其学科涵盖哲学、经济学、法学、教育学、文学、历史学、艺术学、理学、工学、农学、医学、管理学、交叉学科等门类。2024年QS世界排名第44位,亚洲大学排名第6位;2023年软科世界大学学术排名中国第3位,世界第33位。
浙江大学“一带一路”国际医学院于2020年12月经过教育部批准,由浙江大学负责办学和管理,坐落于浙江义乌,是一所服务国家“一带一路”倡议的高等医学教育机构,由中国科学院院士、著名生殖医学家黄荷凤担任院长,主要规划设置基础医学、临床医学等医学相关学科,并通过与人文、社科、理科、工科、信息等多学科交叉融合发展“新医科”体系,校园于2023年10月10日正式启用。现有学生700余名,本科生200余名,研究生500余名,来自中国、美国、意大利、巴西、泰国、赞比亚等49个国家。
浙江大学国际健康医学研究院是国家生物药技术创新中心“一带一路”国际合作基地,获批浙江省首批省级新型研发机构、未来病理浙江省工程研究中心、国家级博士后工作站,聚力打造生殖医学、肿瘤医学、再生与衰老医学、代谢医学、RNA医学、遗传医学、膜受体与脑医学中心,开展高水平的临床转化和前沿性的多学科合作。
浙江大学“一带一路”国际医学院、浙江大学国际健康医学研究院与浙江大学医学院附属第四医院共同以 “三院一体”的发展模式,打造世界一流国际医学中心。浙江大学医学院附属第四医院是浙江大学直属附属医院,省级综合性三甲医院。医院地处浙中义乌,于2014年10月开业。在2022年三级公立医院绩效考核中排名第77名,国考连续四年A+,排名全国前5%。
厚积浙江大学的百年办学特色,围绕国家战略需求和“双一流”建设部署,“三院一体”的创新发展模式,旨在打造国际化、高水平、研究型高等教育科研机构和科研中心,探索引领新医科的“在地国际化”,开启教育对外开放的新征程。
【Introduction of Unit】
Zheiiang University (ZJU), recognized both domestically and internationally, stands out as a comprehensive and research-oriented institution, celebrated for its innovative approach and unique characteristics. The university boasts a diverse array of disciplines, including but not limited to philosophy, economics, and medicine. ZJU has earned high esteem in the academic community, reflected by its notable positions in various global university rankings. Specifically, in the QS World University Rankings 2024, ZJU is ranked 44th, while in the QS Asian University Rankings 2024, it achieves the 6th position. Moreover, the university holds a prestigious 3rd place in China according to the 2023 Academic Ranking of World Universities (ARWU), and ranks 33rd globally in the ARWU World Rankings.
The International School of Medicine, Zhejiang University (ISM) operates as a subsidiary college under the administration of Zhejiang University. It is poised to evolve into a premier institution for higher medical education, aligned with the national "Belt and Road" initiative. The school is led by Dean Huang Hefeng, an esteemed academician from the Chinese Academy of Sciences and a renowned expert in reproductive medicine. There are currently over 700 students, including nearly 200 undergraduate students and over 500 graduate students, from 49 countries including China, the United States, Italy, Brazil, Thailand, and Zambia,etc.
The International Institutes of Medicine, Zhejiang University (IIM) is under the jurisdiction of the International School Medical for management and functions as the "Belt and Road" international cooperation base for the National Center of Technology Innovation in Biopharmaceuticals, has been recognized as one of the first batch of new provincial-level R&D institutions in Zhejiang Province, the Zhejiang Engineering Research Center for Future Pathology and Postdoctoral Workstations. It has established an international and cutting-edge research team and developed several specialized centers, including those for Reproductive, RNA, Oncology, Regeneration and Aging, Metabolic,Genomics,Membrane receptors and Brain Medicine. Committed to high-level clinical translation and groundbreaking multidisciplinary collaboration, IIM is at the forefront of advancing medical research and practice.
The International School of Medicine and the International Institutes of Medicine at Zhejiang University, together with the Fourth Affiliated Hospital of Zhejiang University School of Medicine (ZJU4H), form a strategic alliance to build a world-class international medical center. ZJU4H is a directly affiliated hospital of Zhejiang University and a provincial comprehensive three-A hospital. The hospital is located in Yiwu, central Zhejiang Province and opened in October 2014. Ranked 77th in the performance appraisal of third-level public hospitals in 2022, and ranked A+ for four consecutive years in the national examination, ranking in the top 5% in the country.
Focusing on addressing national strategic priorities and implementing the "double first-class" initiatives based on the century-old characteristics of Zhejiang University, this tripartite model is designed to establish an internationally recognized, innovative, and research-driven institute for advanced medical education. The primary goal of this alliance is to explore how local internationalization can spur innovation in medical science. It also seeks to embark on a novel educational journey that prioritizes global engagement and collaboration.